The recommended dosage is a 10 mg subcutaneous injection, taken three days on and three days off, for 15 days , typically repeated twice a year for best results
If you have a deductible for prescriptions, use the Drug Pricing Tool to learn how much your drugs may cost before you reach the annual deductible
The combination of lab testing, dietitian access, hormone-aware prescribing, and insurance acceptance makes it one of the most comprehensive GLP-1 programs available
Endothelial Nitric Oxide Production
Approved Use While tesamorelin has FDA approval, it's important to understand the regulatory framework: On-label (approved): Prescription Egrifta for HIV-associated lipodystrophy Off-label: Any use outside the approved indication (physicians may prescribe off-label, but this is not FDA-endorsed) Research use: Laboratory-grade tesamorelin for investigational purposes Compounding Regulations Because tesamorelin IS FDA-approved (unlike BPC-157 or TB-500), compounding rules differ